Bayer stops blood thinner drug trial for lack of effect in major setback, World News - AsiaOne
Por um escritor misterioso
Descrição
Germany's Bayer has aborted a large late-stage trial testing a new anti-clotting drug for lack of efficacy, dealing a fresh blow to the embattled drugmaker and throwing its most promising medium-term development project in doubt. It said in a statement late on Sunday that experimental anticoagulant asundexian, which it had hoped would generate annual sales of more than 5 billion
Dahua Joins United Nations Global Compact Initiative to Promote Global Sustainable Development, Business News - AsiaOne
CUHK-SMU Global Forum 2023 - A Whole New World with Computational Social Science (CSS): Transdisciplinary Insight, Business News - AsiaOne
Official Global Release of the New Mobile Puzzle Game 'Pucca Puzzle Adventure' on January 26, Business News - AsiaOne
/cloudfront-us-east-2.images.arcpublishing.com/reuters/FIMW37L37ZNYBB5IODUPLT47GU.jpg)
Bayer woes pile up as blood thinner drug trial fails
No vaccine, no French Open for Djokovic, says France's ministry, World News - AsiaOne
DHL Global Forwarding Asia Pacific certified as Top Employer 2022 third time in a row, Business News - AsiaOne
Japan companies punished over dodgy 'antibacterial' labels, Health News - AsiaOne
Bayer woes pile up as blood thinner drug trial fails
Millionaires group calls for wealth tax at WEF's virtual Davos summit, World News - AsiaOne
Govee is Amplifying Users' Gaming Station with Razer Chroma RGB™, Business News - AsiaOne
Covid-19 pill Paxlovid to be rolled out in phases: MOH, Singapore News - AsiaOne
Bayer shares plunge after blood-thinning drug trial halted
Palestinian Red Crescent, UN agencies evacuate Al Shifa premature babies, World News - AsiaOne
Lingnan scholars listed in World's Top 2% Scientists by Stanford University, Business News - AsiaOne
Canon bolsters its colour production digital press portfolio with the new imagePRESS V900 series, Business News - AsiaOne
